Locust Walk Acquisition registered to offer 13 million units at $10 per unit to raise $130 million in an IPO.
The SPAC is focusing on the healthcare sector or healthcare-related industries in the United States and Europe, especially companies in the life sciences sector.
Locust Walk plans to list on the Nasdaq under LWACU. Common stock and warrants that begin separate trading will list under LWAC and “LWACW, respectively. Read more.
